Regulatory Affairs
Strategic Regulatory Thinking. Confident Execution.
Strategic Regulatory Thinking. Confident Execution.
Regulatory Affairs is fundamental to successful product development, market entry, and lifecycle management. The right regulatory strategy does more than satisfy agency requirements; it helps organisations make informed decisions, anticipate challenges, and protect the long-term value of their innovations.
At Amodaia, we combine scientific understanding, regulatory judgement, and practical experience to help biotech, pharmaceutical, and medical technology organisations navigate complex regulatory environments across global markets.
From early development and regulatory pathway selection to scientific advice, submission planning and lifecycle management, we provide senior-led strategic guidance supported by specialist regulatory writing and execution capabilities.
Whether you need an experienced regulatory adviser, additional expertise for a critical milestone or hands-on support preparing submission documentation, we adapt our involvement to your organisation's needs.
Our Services Include:
- Global regulatory strategy, development planning, and pathway assessment
- Regulatory intelligence, gap analysis, and strategic risk assessment
- Scientific advice preparation and regulatory agency interactions (EMA, FDA and other authorities)
- Orphan Drug Designation (ODD) and expedited regulatory pathway support, including PRIME, Fast Track, and Breakthrough Therapy Designation
- Regulatory submission strategy, planning, and coordination
- Regulatory writing and preparation of CTD Modules 2, 4 and 5, including clinical summaries, study reports, and integrated documents
- Cross-document consistency, scientific review, and submission quality control
- Regulatory lifecycle management, variations, and
- CMC regulatory documentation and submission support in collaboration with specialist CMC teams
Our approach combines strategic regulatory judgement with the technical expertise needed to translate development plans into high-quality, submission-ready documentation.
Where cross-functional alignment is critical, our Narrative Integrity Framework™ helps connect regulatory evidence, scientific claims, and wider development strategy.
Case Studies
Biotech | Switzerland – Regulatory
Writing & Dual-Agency Submission Support
Solution: Amodaia provided senior regulatory and scientific writing expertise to establish a coherent evidence position, align clinical summaries and supporting documentation, and coordinate cross-functional inputs across the submission workstreams.
Impact: Delivered submission-ready dossiers on time, reducing review-cycle friction and aligning agency expectations with internal strategy.